Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bionomics Limited (BNOX)

7.22   0 (0%) 09-24 15:20
Open: 7.71 Pre. Close: 7.22
High: 7.92 Low: 7.2
Volume: 2 Market Cap: 49(M)
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.94 - 7.98 7.98 - 8.01
Low: 7.1 - 7.15 7.15 - 7.19
Close: 7.15 - 7.23 7.23 - 7.29

Technical analysis

as of: 2022-09-23 4:22:40 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 10.05     One year: 11.35
Support: Support1: 6.8    Support2: 5.66
Resistance: Resistance1: 8.6    Resistance2: 9.72
Pivot: 7.86
Moving Average: MA(5): 7.27     MA(20): 7.86
MA(100): 7.36     MA(250): 0
MACD: MACD(12,26): -0.1     Signal(9): 0
Stochastic oscillator: %K(14,3): 14     %D(3): 16.1
RSI: RSI(14): 44.3
52-week: High: 14.5  Low: 5.69
Average Vol(K): 3-Month: 1 (K)  10-Days: 1 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ BNOX ] has closed above bottom band by 27.2%. Bollinger Bands are 75.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.

Headline News

Wed, 21 Sep 2022
Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder - Bluefield Daily Telegraph

Sat, 17 Sep 2022
Reds prospects: 2 outfielders who will be added to the roster, 1 who will not - Blog Red Machine

Thu, 15 Sep 2022
Can Bionomics Limited Unsponsored ADR (BNOX) Climb 329% to Reach the Level Wall Street Analysts Expect? - Nasdaq

Thu, 25 Aug 2022
Bionomics reports Full Year Financial Results - GlobeNewswire

Mon, 08 Aug 2022
Bionomics Receives R&D Tax Incentive Refund for FY2021 of A$2.1M - Yahoo Finance

Fri, 29 Jul 2022
Quarterly Activities Report for June 2022 - GlobeNewswire

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 8 (M)
% Held by Insiders 4.74e+006 (%)
% Held by Institutions 0 (%)
Shares Short 4 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.705e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -3
Return on Assets (ttm) 603.4
Return on Equity (ttm) -22.7
Qtrly Rev. Growth 492370
Gross Profit (p.s.) -26.87
Sales Per Share -21.25
EBITDA (p.s.) -1.80224e+006
Qtrly Earnings Growth -2.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow -19 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.34
Price to Cash Flow 2.33

Stock Dividends

Dividend 0
Forward Dividend 1990
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.